Jose Luis
Royo Sanchez Palencia
Investigador en el periodo 2002-2012
Hospital Universitario de Valme
Sevilla, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario de Valme (11)
2024
-
An Insertion Within SIRPβ1 Shows a Dual Effect Over Alzheimer's Disease Cognitive Decline Altering the Microglial Response
Journal of Alzheimer's Disease, Vol. 98, Núm. 2, pp. 601-618
2023
2022
-
New insights into the genetic etiology of Alzheimer's disease and related dementias
Nature genetics, Vol. 54, Núm. 4, pp. 412-436
2021
-
Common variants in Alzheimer's disease and risk stratification by polygenic risk scores
Nature communications, Vol. 12, Núm. 1, pp. 3417
-
Genomic characterization of host factors related to SARS-CoV-2 infection in people with dementia and control populations: The GR@ACE/DEGESCO study
Journal of Personalized Medicine, Vol. 11, Núm. 12
2020
-
Toll-Like Receptor 2 Promoter -196 to -174 Deletion Affects CD4 Levels Along Human Immunodeficiency Virus Infection Progression
The Journal of infectious diseases, Vol. 222, Núm. 12, pp. 2007-2011
2010
-
Variations in the promoter region of the glutaminase gene and the development of hepatic encephalopathy in patients with cirrhosis: A cohort study
Annals of Internal Medicine, Vol. 153, Núm. 5, pp. 281-288
2009
-
La Atención Primaria en los programas de cuidados paliativos. Análisis de una serie de 34 pacientes
Semergen, Vol. 35, Núm. 3, pp. 115-121
2006
-
Fixed-dose low-molecular-weight heparin, bemiparin, in the long-term treatment of venous thromboembolism in patients with transient risk factors in standard clinical practice: The FLEBUS study [7]
Journal of Thrombosis and Haemostasis
-
Genetic analysis of CAV1 gene in hypertension and metabolic syndrome
Thrombosis and Haemostasis, Vol. 95, Núm. 4, pp. 696-701